Nasrollah Hakami

1.4k total citations
28 papers, 880 citations indexed

About

Nasrollah Hakami is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Nasrollah Hakami has authored 28 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Genetics. Recurrent topics in Nasrollah Hakami's work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Nasrollah Hakami is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Nasrollah Hakami collaborates with scholars based in United States, Canada and South Africa. Nasrollah Hakami's co-authors include George P. Canellos, Paul E. Neiman, Jack Lazerson, Thomas H. Shepard, Werner A. Bleyer, Javad H. Kashani, Donald Pious, ML Cleary, LS Frankel and DJ Pullen and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Nasrollah Hakami

27 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasrollah Hakami United States 14 331 292 209 198 157 28 880
E. Fred Saunders Canada 20 540 1.6× 233 0.8× 274 1.3× 109 0.6× 173 1.1× 54 1.3k
Christine Bender‐Götze Germany 11 620 1.9× 87 0.3× 256 1.2× 110 0.6× 190 1.2× 15 999
Ergül Tunçbılek Türkiye 20 90 0.3× 274 0.9× 82 0.4× 136 0.7× 188 1.2× 55 831
L. de Lumley France 20 300 0.9× 176 0.6× 270 1.3× 45 0.2× 266 1.7× 45 1.0k
C Bernasconi Italy 16 499 1.5× 149 0.5× 126 0.6× 136 0.7× 122 0.8× 55 905
Steven J. Culbert United States 17 269 0.8× 118 0.4× 240 1.1× 28 0.1× 182 1.2× 38 898
Gülersu İrken Türkiye 14 296 0.9× 105 0.4× 87 0.4× 51 0.3× 139 0.9× 64 631
Y. B. Gordon United Kingdom 19 209 0.6× 163 0.6× 283 1.4× 43 0.2× 408 2.6× 56 1.3k
Jörn‐Sven Kühl Germany 16 207 0.6× 302 1.0× 221 1.1× 24 0.1× 133 0.8× 43 905
Carl Pochedly United States 15 86 0.3× 178 0.6× 88 0.4× 57 0.3× 72 0.5× 68 748

Countries citing papers authored by Nasrollah Hakami

Since Specialization
Citations

This map shows the geographic impact of Nasrollah Hakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasrollah Hakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasrollah Hakami more than expected).

Fields of papers citing papers by Nasrollah Hakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasrollah Hakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasrollah Hakami. The network helps show where Nasrollah Hakami may publish in the future.

Co-authorship network of co-authors of Nasrollah Hakami

This figure shows the co-authorship network connecting the top 25 collaborators of Nasrollah Hakami. A scholar is included among the top collaborators of Nasrollah Hakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasrollah Hakami. Nasrollah Hakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubowy, Ronald L., Michael M. Graham, Nasrollah Hakami, et al.. (2008). Sequential Oral Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia. Journal of Pediatric Hematology/Oncology. 30(5). 353–357. 3 indexed citations
2.
Naumann, David N, et al.. (2002). Warm autoimmune hemolytic anemia with mimicking anti-c and -E specificities. Immunohematology. 18(1). 19–22. 8 indexed citations
3.
Rubnitz, Jeffrey E., ML Cleary, LS Frankel, et al.. (1997). Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia. Leukemia. 11(7). 979–983. 7 indexed citations
4.
Rubnitz, Jeffrey E., MP Link, JJ Shuster, et al.. (1994). Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 84(2). 570–573. 134 indexed citations
5.
Hakami, Nasrollah, et al.. (1993). CD45 expression and prognosis in acute lymphoblastic leukemia [letter; comment]. Blood. 81(2). 562–563. 7 indexed citations
6.
Hakami, Nasrollah, et al.. (1987). Acute Nonlymphocytic Leukemia in Children. Hematology/Oncology Clinics of North America. 1(4). 567–575.
7.
Hakami, Nasrollah, A. Thomas Look, P Steuber, et al.. (1987). Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study.. Journal of Clinical Oncology. 5(7). 1022–1025. 23 indexed citations
8.
Miles, Judith H., et al.. (1986). Translocation (4;11) in acute myelogenous leukemia. Cancer Genetics and Cytogenetics. 22(2). 143–148. 6 indexed citations
9.
Hakami, Nasrollah, et al.. (1985). Pseudotumor of hemophilia in the orbit: The role of radiotherapy in management. American Journal of Hematology. 19(1). 99–104. 28 indexed citations
10.
Hakami, Nasrollah, et al.. (1985). Disseminated histiocytosis X complicated by diffuse erythrophagocytosis: report of two cases.. PubMed. 16(5-6). 613–24. 4 indexed citations
11.
Perry, Michael C., et al.. (1983). Osteosarcoma—A complication of chemotherapy for Hodgkinʼs disease in children. American Journal of Clinical Oncology. 6(1). 75–80. 11 indexed citations
12.
Hakami, Nasrollah, et al.. (1983). Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy doses. British Journal of Radiology. 56(665). 343–345. 53 indexed citations
13.
Kashani, Javad H. & Nasrollah Hakami. (1982). Depression in Children and Adolescents with Malignancy*. The Canadian Journal of Psychiatry. 27(6). 474–477. 55 indexed citations
14.
Perry, Michael C., et al.. (1981). Osteogenic sarcoma following Hodgkin's disease. Cancer. 48(2). 416–418. 1 indexed citations
15.
Bauer, John H., et al.. (1979). Congenital mesoblastic nephroma presenting with primary reninism. The Journal of Pediatrics. 95(2). 264–265. 24 indexed citations
16.
Hunter, Robert E. & Nasrollah Hakami. (1972). The occurrence of congenital hypoplastic anemia in half brothers. The Journal of Pediatrics. 81(2). 346–348. 23 indexed citations
17.
Bleyer, Werner A., Nasrollah Hakami, & Thomas H. Shepard. (1971). The development of hemostasis in the human fetus and newborn infant. The Journal of Pediatrics. 79(5). 838–853. 137 indexed citations
18.
Hakami, Nasrollah, Paul E. Neiman, George P. Canellos, & Jack Lazerson. (1971). Neonatal Megaloblastic Anemia Due to Inherited Transcobalamin II Deficiency in Two Siblings. New England Journal of Medicine. 285(21). 1163–1170. 201 indexed citations
19.
Hakami, Nasrollah & Donald Pious. (1968). Mitochondrial enzyme activity in “senescent” and virus-transformed human fibroblasts. Experimental Cell Research. 53(1). 135–138. 12 indexed citations
20.
Hakami, Nasrollah & Donald Pious. (1967). Regulation of Cytochrome Oxidase in Human Cells in Culture. Nature. 216(5120). 1087–1090. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026